HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

NCT05787535 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer
Head and Neck Squamous Cell Carcinoma
Oropharyngeal Cancer
Vagina Tumor
Carcinoma of Penis
Anal Carcinoma
Carcinoma of Vulva

Interventions

DRUG: Fludarabine + Cyclophosphamide
BIOLOGICAL: HRYZ-T101 TCR-T Cell

Sponsor

HRYZ Biotech Co.